SI Exposure · Rank 5 of 100 · Health Care
Eli Lilly and Company (LLY) and SI
8 of Eli Lilly and Company's 11 10-K, 10-Q and 8-K filings in the last four full quarters (Q4 2025 to Q3 2026) contain "artificial intelligence" or the new name: 72.7%, rank 5 of the 100 largest US companies. It has not used the new name, "super intelligence" or "superintelligence", in any SEC filing so far. Counts come from SEC EDGAR full text search, Nov 11, 2026.
Over time
Eli Lilly and Company filings, quarter by quarter
Since Q1 2023: how many 10-K, 10-Q and 8-K filings Eli Lilly and Company made each quarter and how many contain "artificial intelligence" or "super intelligence" or "superintelligence".
| Quarter | Filings | Old name | New name | Share |
|---|---|---|---|---|
| Q4 2026 | 2 | 2 | 0 | 100.0% |
| Q3 2026 | 2 | 2 | 0 | 100.0% |
| Q2 2026 | 4 | 2 | 0 | 50.0% |
| Q1 2026 | 2 | 2 | 0 | 100.0% |
| Q4 2025 | 3 | 2 | 0 | 66.7% |
| Q3 2025 | 3 | 2 | 0 | 66.7% |
| Q2 2025 | 3 | 2 | 0 | 66.7% |
| Q1 2025 | 4 | 3 | 0 | 75.0% |
| Q4 2024 | 3 | 2 | 0 | 66.7% |
| Q3 2024 | 6 | 2 | 0 | 33.3% |
| Q2 2024 | 4 | 2 | 0 | 50.0% |
| Q1 2024 | 3 | 2 | 0 | 66.7% |
| Q4 2023 | 2 | 0 | 0 | 0.0% |
| Q3 2023 | 2 | 0 | 0 | 0.0% |
| Q2 2023 | 3 | 0 | 0 | 0.0% |
| Q1 2023 | 4 | 0 | 0 | 0.0% |
Filings with the new name
None yet. When Eli Lilly and Company first files a document with "super intelligence" or "superintelligence", it appears here with a link.
Latest filings with "artificial intelligence"
Embed
Put this card on any page
A plain image that links back here: no script, no cookies. It shows the latest build's numbers and its source. Free to use under CC BY 4.0.
<a href="https://tsio.si/exposure/lly/"><img src="https://tsio.si/exposure/lly/card.svg" width="480" height="220" alt="SI Exposure of Eli Lilly and Company: 72.7% of its 10-K, 10-Q and 8-K filings contain "artificial intelligence""></a>
Compare